# US 2023/0265477 A1 · Novel enzymatic methods to generate high yields of sequence specific rna oligonucleotides with extreme precision

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0265477 A1
- Document ID: US20230265477A1
- Status: Published application
- Kind: A1
- Application number: 18/152,367
- Filed: 2023-01-10
- Published: 2023-08-24
- Earliest claimed: 2019-04-24
- Assignees: University of Massachusetts
- Applicants: University Of Massachusetts
- Inventors: Craig Martin; Elvan Cavac; Kithmie Harshana Malagodapathiranage; Shuo Sui; Sarah L. Perry; Yasaman Gholamalipour
- Web page: https://patentgrep.com/patent/US20230265477A1

## CPC

- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12N 9/1247: {DNA-directed RNA polymerase (2.7.7.6)}
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12Q 1/6865: Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Described herein are synthetic methods for producing sequence-specific RNA oligonucleotides that eliminate impurities produced in prior art methods. In one aspect, an end-protected capture DNA complementary to a portion of the product RNA is employed. In another aspect, the template DNA is covalently or noncovalently linked to the RNA polymerase, either directly or through the use of a nontemplate DNA. In a third aspect, a flow chamber is employed. All of the methods can be used in combination.

## Claims

### Claim 1

A method of synthesizing a product RNA, the method comprising
preparing a reaction mixture comprising a functional template DNA for the product RNA, and an RNA polymerase under conditions for RNA synthesis, wherein the RNA polymerase is covalently or noncovalently linked to a nontemplate DNA that is 10 nucleotides or longer in length, and wherein the nontemplate DNA is complementary to a minimum of 10 nucleotides of the template DNA upstream of the transcription start site, or wherein the nontemplate DNA is complementary to all or part of the entire template strand DNA in the coding region, wherein the nontemplate DNA and the RNA polymerase are immobilized to a solid support, and wherein the reaction mixture and the solid support are contained in a reaction chamber of a fluidic chip, the fluidic chip comprising fluidic paths for reagent delivery and product RNA removal, and
synthesizing the product RNA in the reaction mixture and continuously removing the product RNA from the reaction chamber while flowing fresh RNA synthesis reagents into the reaction chamber,
wherein the RNA polymerase comprises an avidin-binding peptide, the nontemplate DNA comprises a 3′ or 5′ biotin label respectively, and the RNA polymerase is noncovalently linked to the nontemplate DNA via a bead support that binds both the avidin-binding peptide and the biotin.

### Claim 2 (depends on 1)

The method of claim 1, wherein the reaction chamber is in operable communication with a downstream chamber comprising an immobilized reagent that specifically binds full-length product RNA, wherein the immobilized reagent does not bind less than full-length RNA and double-stranded RNA impurities.

### Claim 3 (depends on 1)

The method of claim 1, wherein the support is a microparticle or a bead.

### Claim 4 (depends on 1)

The method of claim 1, wherein RNA synthesis is conducted under low salt conditions of 0 to 50 mM.

### Claim 5 (depends on 1)

The method of claim 1, wherein RNA synthesis is conducted under high salt conditions of 50 to 1000 mM.

### Claim 6 (depends on 1)

The method of claim 1, wherein the reaction mixture further comprises a capture DNA that is 3′ end protected, and is complementary to 8 to 20 nucleotides at the 3′ end of the product RNA.

### Claim 7 (depends on 6)

The method of claim 6, wherein the 3′ end of the capture DNA comprises 3′ amino, 3′-deoxy (H), 3′-phosphorylation, 3′-O-methyl, 3′-fluorophore, 3′-biotin, 3′-azide, 3′-fluoro, 3′-PEG, or a 3′-mismatched base.

### Claim 8 (depends on 1)

The method of claim 1, further comprising purifying the product RNA.

### Claim 9 (depends on 8)

The method of claim 8, further comprising removing the capture DNA after product RNA synthesis.

### Claim 10

A method of synthesizing a product RNA, the method comprising,
preparing a reaction mixture comprising a functional template DNA for the product RNA, and an RNA polymerase under conditions for RNA synthesis, wherein the RNA polymerase is covalently or noncovalently linked to a nontemplate DNA that is 10 nucleotides or longer in length, and wherein the nontemplate DNA is complementary to a minimum of 10 nucleotides of the template DNA upstream of the transcription start site, or wherein the nontemplate DNA is complementary to all or part of the entire template strand DNA in the coding region, wherein the nontemplate DNA and the RNA polymerase are immobilized to a solid support, and wherein the reaction mixture and the solid support are contained in a reaction chamber of a fluidic chip, the fluidic chip comprising fluidic paths for reagent delivery and product RNA removal, and
synthesizing the product RNA in the reaction mixture and continuously removing the product RNA from the reaction chamber while flowing fresh RNA synthesis reagents into the reaction chamber,
wherein the RNA polymerase comprises a haloalkane dehalogenase tag, and wherein the nontemplate DNA is covalently linked to the haloalkane dehalogenase tag of the RNA polymerase via a 3′ or 5′halogen-modification.

### Claim 11 (depends on 10)

The method of claim 10, wherein the reaction chamber is in operable communication with a downstream chamber comprising an immobilized reagent that specifically binds full-length product RNA, wherein the immobilized reagent does not bind less than full-length RNA and double-stranded RNA impurities.

### Claim 12 (depends on 10)

The method of claim 10, wherein the support is a microparticle or a bead.

### Claim 13 (depends on 10)

The method of claim 10, wherein RNA synthesis is conducted under low salt conditions of 0 to 50 mM.

### Claim 14 (depends on 10)

The method of claim 10, wherein RNA synthesis is conducted under high salt conditions of 50 to 1000 mM.

### Claim 15 (depends on 10)

The method of claim 10, wherein the reaction mixture further comprises a capture DNA that is 3′ end protected, and is complementary to 8 to 20 nucleotides at the 3′ end of the product RNA.

### Claim 16 (depends on 15)

The method of claim 15, wherein the 3′ end of the capture DNA comprises 3′ amino, 3′-deoxy (H), 3′-phosphorylation, 3′-O-methyl, 3′-fluorophore, 3′-biotin, 3′-azide, 3′-fluoro, 3′-PEG, or a 3′-mismatched base.

### Claim 17 (depends on 10)

The method of claim 10, further comprising purifying the product RNA.

### Claim 18 (depends on 17)

The method of claim 17, further comprising removing the capture DNA after product RNA synthesis.
